(Q38263489)

1 September 2017

1 reference

title

Update on epidemiology of and preventive strategies for invasive fungal infections in cancer patients (English)

1 reference

invasive fungal infections

1 September 2017

1 reference

1 reference

1

John R Perfect

1 reference

1 September 2017

Ray Hachem

2

1 reference

1 September 2017

John R Wingard

series ordinal

3

1 reference

1 September 2017

language of work or name

English

0 references

publication date

1 November 2014

1 reference

Clinical Infectious Diseases

1 September 2017

published in

1 reference

1 September 2017

volume

59 Suppl 5

1 reference

1 September 2017

page(s)

S352-5

1 reference

The impact of prior invasive mold infections in leukemia patients who undergo allo-SCT in the era of triazole-based secondary prophylaxis

1 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU639

Hema e-Chart registry of invasive fungal infections in haematological patients: improved outcome in recent years in mould infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU639

Posaconazole vs. fluconazole or itraconazole prophylaxis in patients with neutropenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU639

Clinical effectiveness of posaconazole versus fluconazole as antifungal prophylaxis in hematology-oncology patients: a retrospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU639

Epidemiology and sites of involvement of invasive fungal infections in patients with haematological malignancies: a 20-year autopsy study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU639

Rare opportunistic (non-Candida, non-Cryptococcus) yeast bloodstream infections in patients with cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU639

Increasing echinocandin resistance in Candida glabrata: clinical failure correlates with presence of FKS mutations and elevated minimum inhibitory concentrations

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU639

Toll-like receptor 4 polymorphisms and aspergillosis in stem-cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU639

Human genetic susceptibility to Candida infections.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU639

A controlled trial of fluconazole to prevent fungal infections in patients undergoing bone marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU639

Voriconazole for secondary prophylaxis of invasive fungal infections in allogeneic stem cell transplant recipients: results of the VOSIFI study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU639

Impact of the intensity of the pretransplantation conditioning regimen in patients with prior invasive aspergillosis undergoing allogeneic hematopoietic stem cell transplantation: A retrospective survey of the Infectious Diseases Working Party of th

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU639

Aerosolized liposomal amphotericin B for the prevention of invasive pulmonary aspergillosis during prolonged neutropenia: a randomized, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU639

Intravenous and oral itraconazole versus intravenous and oral fluconazole for long-term antifungal prophylaxis in allogeneic hematopoietic stem-cell transplant recipients. A multicenter, randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU639

Itraconazole versus fluconazole for prevention of fungal infections in patients receiving allogeneic stem cell transplants

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU639

Posaconazole or fluconazole for prophylaxis in severe graft-versus-host disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU639

Randomized, double-blind trial of fluconazole versus voriconazole for prevention of invasive fungal infection after allogeneic hematopoietic cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU639

Breakthrough zygomycosis after voriconazole treatment in recipients of hematopoietic stem-cell transplants

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU639

Invasive zygomycosis in hematopoietic stem cell transplant recipients receiving voriconazole prophylaxis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU639

Zygomycosis in a tertiary-care cancer center in the era of Aspergillus-active antifungal therapy: a case-control observational study of 27 recent cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU639

Voriconazole versus itraconazole for antifungal prophylaxis following allogeneic haematopoietic stem-cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU639

Prospective surveillance for invasive fungal infections in hematopoietic stem cell transplant recipients, 2001-2006: overview of the Transplant-Associated Infection Surveillance Network (TRANSNET) Database.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU639

Aspergillosis due to voriconazole highly resistant Aspergillus fumigatus and recovery of genetically related resistant isolates from domiciles

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU639

Galactomannan and computed tomography-based preemptive antifungal therapy in neutropenic patients at high risk for invasive fungal infection: a prospective feasibility study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU639

A prospective randomized controlled trial comparing PCR-based and empirical treatment with liposomal amphotericin B in patients after allo-SCT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU639

21 January 2018

Identifiers

DOI

10.1093/CID/CIU639

1 reference

1 September 2017

1 reference